Harvard Bioscience Stock
Price
Target price
€0.49
€0.49
1.660%
0.008
1.660%
-
21.01.26 / Frankfurt
WKN: 578107 / Symbol: HBIO / Name: Harvard / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Harvard Bioscience Stock
Harvard Bioscience gained 1.660% today.
So far the community has only identified positive things for Harvard Bioscience stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Harvard Bioscience in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Cons
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Harvard Bioscience vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Harvard Bioscience | 1.660% | -2.823% | -24.688% | -73.516% | -12.364% | -80.720% | -86.149% |
| MicroVision Inc | -1.000% | -7.022% | -7.502% | -51.091% | 0.816% | -65.417% | -86.498% |
| Fonar Corp. New | - | 0.000% | 25.397% | 8.966% | 1.282% | -7.602% | 1.282% |
| Fluidigm Corp. | 0.000% | -5.926% | -8.633% | -26.590% | 19.811% | -30.411% | -73.386% |
Comments
Harvard Bioscience, Inc. (NASDAQ: HBIO) had its price target raised by analysts at Benchmark Co. from $3.00 to $4.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HBIO provided by MarketBeat
News
Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns
In the last few months of 2025, shares of pharmaceutical giant Eli Lilly and Company (NYSE: LLY) went on an undeniable hot streak. From the beginning of August 2025 to the end of the year, the
Billionaire Ken Griffin Just Bought a Quantum Computing Stock That Could Soar by as Much as 101%, According to Wall Street
When it comes to famous investment personalities, names such as Warren Buffett or Jamie Dimon usually get mentioned first. In the world of hedge funds, though, Ken Griffin is the cream of the crop.
How Does Meta Make Money?
Meta Platforms (NASDAQ: META) has come a long way from its origins as a platform to connect students to its current status as a social media powerhouse and leader in the ongoing artificial